Browsing Tag
Fasinumab
2 posts
How Levicept Ltd. is advancing neurotrophin-3 inhibition in osteoarthritis treatment
Levicept Ltd.’s LEVI-04 Phase II data could reshape osteoarthritis treatment. Discover what this means for investors, regulators, and drug pipelines.
April 27, 2026
Teva and Regeneron report positive Phase 3 results for Fasinumab in osteoarthritis pain management
Teva Pharmaceutical Industries and Regeneron Pharmaceuticals have announced successful outcomes from their phase 3 study of fasinumab, a…
August 19, 2018